| Stage | HSTM | % of rev | IRMD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $84M | 100.00% | $24M | 100.00% | HSTM ×3.46 |
| Gross profit | $55M | 65.35% | $18M | 76.26% | IRMD +10.9pp |
| Operating income | $8M | 9.94% | $8M | 33.63% | IRMD +23.7pp |
| Pre-tax income | $9M | 10.39% | $9M | 35.81% | IRMD +25.4pp |
| Net income | $7M | 7.96% | $7M | 26.88% | IRMD +18.9pp |
| Stage | HSTM | IRMD | Gap · A − B |
|---|---|---|---|
| Revenue | $84M100.00% | $24M100.00% | HSTM ×3.46 |
| Gross profit | 65.35%$55M | 76.26%$18M | IRMD +10.9pp |
| Operating income | 9.94%$8M | 33.63%$8M | IRMD +23.7pp |
| Pre-tax income | 10.39%$9M | 35.81%$9M | IRMD +25.4pp |
None
No disclosed counterparties: HSTM.
| Net income |
| 7.96%$7M |
| 26.88%$7M |
| IRMD +18.9pp |